Skip to Main Content

Paper Details

<i>PTEN</i> loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles.
Oncotarget
26
2017
ATP11A, CpG, CpG sites, CpGs, GDNF, JAK1, JAM3, PCa, PTEN, PTEN genomic, Patients, Prostate cancer, Prostate tumors, Tumor, VAPA, homo- versus hemizygous deleted tumors, methylated CpGs, patients, prostate cancer, tumor, tumor suppressor gene, tumors
Author NameAffiliation
Jonathan L WrightFred Hutchison Cancer Research Center
Jonathan L WrightUniversity of Washington School of Medicine
Marina BibikovaInc.
Marina BibikovaInc.
Brandy KlotzleInc.
Jian-Bing FanInc.
Jian-Bing Fan
Jian-Bing FanInc.
Jian-Bing Fan
Elaine A OstranderNational Human Genome Research Institute
Elaine A OstranderNational Human Genome Research Institute
Peter S NelsonDivision of Clinical Research, Fred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington School of Medicine
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonDivision of Clinical Research, Fred Hutchinson Cancer Research Center
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington School of Medicine
Janet L StanfordFred Hutchison Cancer Research Center
Janet L StanfordUniversity of Washington School of Public Health
Janet L StanfordFred Hutchison Cancer Research Center
Janet L StanfordUniversity of Washington School of Public Health
  • 1 - 21

Datasets

Release 1.2